Pharmaceutical Associates recalls
FDA enforcement reports naming Pharmaceutical Associates Inc as the recalling firm.
- Recall reports
- 3
- Class I (serious)
- 0
- Most recent report
- Feb 5, 2020
- Feb 5, 2020Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (…Drug · Pharmaceutical Associates IncSubpotent: Out of specification for assay at the 12-month time point.Class II
- Jun 13, 2018Nystatin Oral Suspension, USP, 500,000 units/5 mL, For Institutional Use Only, package…Drug · Pharmaceutical Associates IncResuspension problems: Out of specification for appearance and resuspendability.Class III
- Nov 12, 2014Cyproheptadine HCl Syrup (Cyproheptadine HCl Oral Solution, USP) 4mg/10 mL, Rx ONLY, Ph…Drug · Pharmaceutical Associates IncFailed Impurities/Degradation Specifications : Out-of-specification result for an unidentified impurity at the 12 month stability test point.Class II